Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in New Drug Approvals

FDA Approves Pediatric Indication for Emend (aprepitant) Capsules in Combination with Other Antiemetic Agents

(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Emend (aprepitant) capsules, a substance P/neurokinin 1 (NK1) receptor antagonist. With this expanded indication, Emend capsules are now approved...

Posted today in Medical

Health Highlights: Sept. 2, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Man's Severely Burned Hand Saved by Implanting It in His Belly Surgeons saved a man's badly burned hand by implanting it in his belly for three weeks in order to give it time to heal and develop a new blood supply. The surgery to tuck 87-year-old...

Posted today in Medical

Could Common Diabetes Drugs Help Fight Leukemia?

Common diabetes drugs might help eradicate drug-resistant cancer cells in a certain form of leukemia when added to standard treatment, a small new study suggests. Researchers found that patients with chronic myeloid leukemia (CML) who received a glitazone -- a class of drug for type 2 diabetes -- along with the standard CML drug imatinib remained disease-free...

Posted today in New Drug Approvals

FDA Approves Varubi (rolapitant) for Chemotherapy-Induced Nausea and Vomiting

The U.S. Food and Drug Administration approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is approved in adults in combination with other drugs (antiemetic agents) that prevent nausea and vomiting associated with initial and repeat courses of vomit-inducing (emetogenic and highly emetogenic)...

Posted 2 days ago in Clinical Trials

OncoMed Pharmaceuticals Completes Enrollment of Phase 2 ALPINE Clinical Trial of Tarextumab in Pancreatic Cancer

OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, today announced that it has completed patient enrollment in its Phase 2 "ALPINE" clinical trial of tarextumab (anti-Notch2/3, OMP-59R5) for the treatment of pancreatic cancer more than eight months ahead of schedule....

Posted today in Medical

Younger Women With Diabetes More Vulnerable to Heart Attack: Study

Young women with diabetes are much more likely to have a heart attack than those without the blood sugar disease, new research says. The study from Poland also found that young women who actually had a heart attack were more likely to be smokers than older women who had suffered heart attacks. To reach these conclusions, the researchers looked at...

Posted today in Medical

Anti-Nausea Drug Varubi Approved

Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among adults undergoing cancer chemotherapy. Nausea and vomiting are common side effects of chemotherapy that can persist for days after the drugs are given. Prolonged bouts of these reactions can lead to weight loss, dehydration and malnutrition,...

Posted today in Medical

Immune Cell Therapy Shows Promise Against Deadly Blood Cancer

An experimental therapy for chronic lymphocytic leukemia (CLL) that uses a patient's own immune cells may cure some patients and prolong survival in others with the blood cancer, researchers report. The process of creating the therapy, called CTL019, begins with a patient's own T cells, which are a type of white blood cell essential for an immune response....

Posted today in Medical

Acupuncture Might Help Ease High Blood Pressure

Can acupuncture benefit people with mildly or moderately elevated blood pressure? Perhaps, a small study suggests, but the researchers behind the trial acknowledge that it's too soon to say for sure. The researchers found that blood pressure levels declined slightly in a small group of patients treated 30 minutes a week with "electroacupuncture" --...

Posted today in Medical

FDA Issues Warning About Skin Lighteners

Injectable skin-lightening products are potentially unsafe and ineffective, the U.S. Food and Drug Administration warns. The agency has not approved any of these products, and they may contain unknown harmful ingredients or contaminants. "These products pose a potentially significant safety risk to consumers. You're essentially injecting an unknown...

Read more news...

Recently added consumer and prescribing information: Varubi, Repatha, Synjardy, Addyi, Daklinza, Praluent, Odomzo, Technivie, Rexulti, Entresto

Posted in Blog

Have you had a medication that you could not afford lately?

If you answered yes, you probably are not alone. The cost of certain prescriptions, like those for hepatitis C, cancer and rheumatoid arthritis, have skyrocketed. Many of these special drugs cannot be accessed from a regular retail pharmacy. The patient must acquire the treatment from a “specialty pharmacy”, that may not even be in their […]

Posted in Blog

Drugs.com Reaches 500,000 Facebook Likes

Drugs.com has topped the 500,000 likes mark on our Facebook page. A huge thank you to the half million dedicated fans who follow our page, like our articles and share our links. We appreciate every single one of you. It is our aim to keep you up-to-date on all things drug related through our daily […]

Posted in Blog

Drug Shortages: Has the FDA Response Made an Impact?

Rationing of much needed medications for patients is a scary thought for me as a healthcare professional. I can understand when an orphan drug may go in short supply for a rare disease, but when commonly used medications like antibiotics and intravenous fluids become scarce, I wonder what the forces are that cause this to […]

See more blog posts or follow us on twitter.

Hide